Would the legalisation of recreational cannabis fill a budget black hole?

Published 03-APR-2020 12:59 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Federal or State governments could consider legalising recreational cannabis to fill the budget black holes they will face post the COVID-19 pandemic.

It is unlikely that Australian governments will consider such action, however it would be foolhardy to scoff at any suggestion that helps to replace the billions, perhaps trillions of dollars spent to prop up the economy.

There are certain states in the US, now considering this measure.

Oklahoma lawmaker Scott Fetgatter has stated COVID-19 job losses and low oil prices have left the state more than $220 million in the red. This will be exacerbated by a further $250 million debt next year.

“With the current situation with oil prices being down, COVID-19, the economic impacts from those things, I just am wondering if it wouldn’t be a good idea to have a discussion in the legislature about a full access program adult use over 21 alongside our medical program,” Fetgatter said.

This type of program is already successful in Colorado, where medical and recreational marijuana sales hit a record $1.75 billion in sales last year.

“Colorado brought in $300 million in tax revenue and license fees last year in the state coffers,” Fetgatter said. “In the first year we legitimately could see $100 million a year in increases rendered to the state of Oklahoma.”

"It's very early in the conversation," Fetgatter told the Tulsa World this week. "What's important to me is to make sure we have a program that functions. A lot of people didn't like medical marijuana, and they may not like marijuana, period. I understand that. But it is here and is not going anywhere."

One Senator who doesn’t like it is Senator Ron Sharp of Shawnee who believes legalisation may actually lead to a surplus of pot and an increase in black market sales.

“When you have farmers overproducing, they’re going to want to sell that. When you have a dispensary that has too much marijuana they’re going to try to slip it out the backdoor,” Sharp said. “It’s just not a very feasible idea.”

New York Governor Andrew Cuomo has also rejected the idea, saying recreational marijuana will not be part of the state budget this year.

The state of New York has a $15 billion budget gap, caused by the fallout from the coronavirus.

"It's not likely," he said. "Too much, too little time."

That sentiment was backed by Liz Krueger, the Senate Finance Committee Chair, who is also the prime sponsor of a bill to legalize cannabis. She told public television’s "New York Now" that the provision is on hold.

“I do not believe that marijuana is going to be negotiated in this budget in the next few days,” Kruger said. “I just don’t see it as realistic.”

Kruger believes the governor and Legislature could not negotiate a complicated measure in the budget to set up a legal marijuana system in New York, with all of the distractions caused by the coronavirus crisis.

Drug Policy Alliance’s Melissa Moore was disappointed in the decision but said it was understandable.

"I don't think anyone could have foreseen the circumstances that we would be operating within as we are in the final days of closing the budget here in New York," said Moore, who added COVID-19 is "rightfully" demanding so much of the lawmakers' attention.

"Not moving to legalize cannabis through the budget process right now ... it makes sense," she said pointing to the fact that at times like these Drug Policy Alliance is more focused on “on day-to-day, life-or-death scenarios”.

Moore said she hopes lawmakers will return to the Capitol later this year and legalise cannabis.

Certainly, in these uncertain times, the legalisation of recreational cannabis could have a positive impact on the economy.

Yet, there is much to consider. From how the legal system would work in this sector, to restrictions and how any revenues feed into the tax system.

It is clear that no government will take this path while they are struggling to keep their respective countries afloat, but it may be worth considering down the track when the true nature of the cost of the COVID-19 pandemic is known.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X